PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332)

NCT03070223 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

602

Enrollment

NETWORK

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: Pitavastatin
DRUG: Placebos

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators

[object Object]
[object Object]